リアルタイム電子ヘルスケアシステム市場Real-Time E-Healthcare System Market リアルタイムのe-ヘルスケアシステムは、地理的な制約を受けることなく、いつでも自分の健康記録を保持し、それを追跡するための最良の方法の一つである。患者は常に医師と連絡を取り合い、どんな健康問題につい... もっと見る
日本語のページは自動翻訳を利用し作成しています。
サマリーリアルタイムのe-ヘルスケアシステムは、地理的な制約を受けることなく、いつでも自分の健康記録を保持し、それを追跡するための最良の方法の一つである。患者は常に医師と連絡を取り合い、どんな健康問題についても医師とコミュニケーションをとることができる。また、第三者に依存することなく、セルフチェックですぐに結果を知ることもできる。高度な技術と急速な技術革新により、最近の製品はより消費者にやさしく、使いやすいように作られている。リアルタイムeヘルスケア・システムは、上記の基準をすべて満たしているため、市場はプラスの成長を遂げている。最近では、Kaiser Permanenteが米国オレゴン州の地域医療センターでEMRプロトコルを導入し、糖尿病患者の臨床判断支援を改善した。 iPatientCare EHR、Praxis、EMR、Insta HMS、e-MDs Chart、WRS Health、AccuMed、WEBeDoctor、A.I.medは、電子カルテ(EMR)ソフトウェアのトップ製品の一部である。 リアルタイムEヘルスケアシステム市場:促進要因と阻害要因 技術の進歩、可処分所得の増加、オンラインサービスの利用増加、モバイル機器の利用増加、医療費と支出の増加、統合医療システムに対するニーズの増加が、リアルタイムeヘルスケアシステム市場の最も重要な推進要因である。リアルタイムeヘルスケアシステムは医療ミスを減らし、情報に簡単にアクセスできるため、リアルタイムeヘルスケアシステムに対する需要は地域を問わず増加している。 経験の浅い専門家の不足、高いメンテナンスとサービスコスト、プライバシーの問題、システムの複雑さ、ヨーロッパのような先進国を含む地方でのリアルタイムeヘルスケアシステムの存在感の薄さなどが、リアルタイムeヘルスケアシステム市場の障壁として作用している。 リアルタイムeヘルスケアシステム市場:セグメンテーション リアルタイムeヘルスケアシステムは、以下のセグメントに大別される。 製品別 フィットネスバンド/リストバンド型デバイス クリップ式モニター機器 体温計 血圧計 Mヘルスアプリケーション 血糖値モニター装置 エンドユーザー別 公立/私立病院 薬局 個人 その他 リアルタイム電子ヘルスケアシステム市場概要 リアルタイムeヘルスケア市場は、可処分所得の増加、消費者の健康意識の向上、高齢化、医療費の増加により、健全なCAGRで大きく成長している。急速な技術進歩と市場で利用可能なさまざまなオプションにより、リアルタイムeヘルスケア市場は世界的な成長が見込まれている。この製品カテゴリーでは、北米が最大の市場を占めている。アジア太平洋地域は、リアルタイムeヘルスケア市場において最も急成長している地域である。 リアルタイムeヘルスケアシステム市場:地域別展望 リアルタイムeヘルスケア市場は、予測期間中に2桁のCAGRを記録すると予測される。地理的地域によって、リアルタイムeヘルスケア市場は7つの主要地域に区分される:北米、南米、東欧、西欧、アジア太平洋、日本、中東・アフリカである。アジア太平洋地域は、医療インフラの改善と高い医療費、可処分所得の増加により、最も急成長している市場である。欧州や北米などの先進国からのクラウドコンピューティング需要の増加も、予測期間終了までにリアルタイムeヘルスケアシステムの需要を増加させる可能性がある。 リアルタイムeヘルスケアシステム市場:主要プレーヤー リアルタイムeヘルスケアの主要市場プレーヤーには、Fitbit、Garmin、Jawbone、Misfit Wearables、DexCom、Medtronic、Abbott、Cerner Corporation、GE Healthcare、Epic Systems Corporation、Medical Information Technology Inc.(MEDITECH)などがある。 この調査レポートは、市場の包括的な評価を提示し、思慮深い洞察、事実、過去のデータ、統計的に裏付けされた、業界で検証された市場データを含んでいます。また、適切な仮定と方法論を用いた予測も含まれています。この調査レポートは、市場セグメント、地域、タイプ、技術、用途などのカテゴリー別に分析と情報を提供しています。 本レポートでは、以下の項目について網羅的に分析しています: 市場セグメント 市場ダイナミクス 市場規模 需要と供給 現在の動向/問題/課題 競合・参入企業 テクノロジー バリューチェーン 地域分析 北米(米国、カナダ) ラテンアメリカ(メキシコ、ブラジル) 西欧(ドイツ、イタリア、フランス、英国、スペイン、北欧諸国、ベルギー、オランダ、ルクセンブルク) 東欧(ポーランド、ロシア) アジア太平洋(中国、インド、ASEAN、オーストラリア、ニュージーランド) 日本 中東・アフリカ(GCC、南アフリカ、北アフリカ) 本レポートは、業界アナリストによる生の情報、質的・量的評価、業界専門家およびバリューチェーン全体にわたる業界参加者からのインプットをまとめたものです。本レポートでは、親市場の動向、マクロ経済指標、支配要因について、セグメントごとの市場魅力とともに詳細に分析しています。また、様々な市場要因が市場セグメントや地域に与える定性的な影響もマッピングしています。 レポートのハイライト 親市場の詳細な概要 業界における市場ダイナミクスの変化 詳細な市場セグメンテーション 過去、現在、そして予測される市場規模(数量ベース、金額ベース 最近の業界動向と発展 競合他社の状況 主要企業の戦略と提供製品 潜在的なニッチセグメント、有望な成長を示す地理的地域 市場パフォーマンスに関する中立的な視点 市場関係者が市場での足跡を維持・強化するための必須情報。 注 - レポートに記載されている事実、意見、分析の記述はすべて各アナリストのものです。これらは必ずしもFuture Market Insightsの正式な立場や見解を反映するものではありません。 目次1. Executive Summary1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Product Life Cycle Analysis 3.5. Supply Chain Analysis 3.5.1. Supply Side Participants and their Roles 3.5.1.1. Producers 3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers) 3.5.1.3. Wholesalers and Distributors 3.5.2. Value Added and Value Created at Node in the Supply Chain 3.5.3. List of Raw Material Suppliers 3.5.4. List of Existing and Potential Buyer’s 3.6. Investment Feasibility Matrix 3.7. Value Chain Analysis 3.7.1. Profit Margin Analysis 3.7.2. Wholesalers and Distributors 3.7.3. Retailers 3.8. PESTLE and Porter’s Analysis 3.9. Regulatory Landscape 3.9.1. By Key Regions 3.9.2. By Key Countries 3.10. Regional Parent Market Outlook 3.11. Production and Consumption Statistics 3.12. Import and Export Statistics 4. Global Real-Time E-Healthcare System Market Analysis 2017-2021 and Forecast, 2022-2032 4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021 4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Real-Time E-Healthcare System Market Analysis 2017-2021 and Forecast 2022-2032, By Product Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Mn) Analysis By Product Type, 2017-2021 5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Product Type, 2022-2032 5.3.1. Wireless Body Sensor Network Based e-healthcare Systems 5.3.2. Cellular and Smartphone Based e-Healthcare Systems 5.3.3. System on Chip e-healthcare System 5.3.4. Cloud-based e-healthcare Systems 5.4. Y-o-Y Growth Trend Analysis By Product Type, 2017-2021 5.5. Absolute $ Opportunity Analysis By Product Type, 2022-2032 Deep-dive segmentation will be available in the sample on request 6. Global Real-Time E-Healthcare System Market Analysis 2017-2021 and Forecast 2022-2032, By Distribution Channel 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Mn) Analysis By Distribution Channel, 2017-2021 6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2022-2032 6.3.1. Institutional Sales 6.3.2. Retail Sales 6.4. Y-o-Y Growth Trend Analysis By Distribution Channel, 2017-2021 6.5. Absolute $ Opportunity Analysis By Distribution Channel, 2022-2032 Deep-dive segmentation will be available in the sample on request 7. Global Real-Time E-Healthcare System Market Analysis 2017-2021 and Forecast 2022-2032, By Region 7.1. Introduction 7.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021 7.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032 7.3.1. North America 7.3.2. Latin America 7.3.3. Europe 7.3.4. East Asia 7.3.5. South Asia & Pacific 7.3.6. MEA 7.4. Market Attractiveness Analysis By Region 8. North America Real-Time E-Healthcare System Market Analysis 2017-2021 and Forecast 2022-2032, By Country 8.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 8.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 8.2.1. By Country 8.2.1.1. U.S. 8.2.1.2. Canada 8.2.2. By Product Type 8.2.3. By Distribution Channel 8.3. Market Attractiveness Analysis 8.3.1. By Country 8.3.2. By Product Type 8.3.3. By Distribution Channel 8.4. Key Takeaways 9. Latin America Real-Time E-Healthcare System Market Analysis 2017-2021 and Forecast 2022-2032, By Country 9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 9.2.1. By Country 9.2.1.1. Brazil 9.2.1.2. Mexico 9.2.1.3. Rest of Latin America 9.2.2. By Product Type 9.2.3. By Distribution Channel 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Product Type 9.3.3. By Distribution Channel 9.4. Key Takeaways 10. Europe Real-Time E-Healthcare System Market Analysis 2017-2021 and Forecast 2022-2032, By Country 10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 10.2.1. By Country 10.2.1.1. Germany 10.2.1.2. U.K. 10.2.1.3. France 10.2.1.4. Spain 10.2.1.5. Italy 10.2.1.6. Rest of Europe 10.2.2. By Product Type 10.2.3. By Distribution Channel 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Product Type 10.3.3. By Distribution Channel 10.4. Key Takeaways 11. East Asia Real-Time E-Healthcare System Market Analysis 2017-2021 and Forecast 2022-2032, By Country 11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 11.2.1. By Country 11.2.1.1. China 11.2.1.2. Japan 11.2.1.3. South Korea 11.2.2. By Product Type 11.2.3. By Distribution Channel 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Product Type 11.3.3. By Distribution Channel 11.4. Key Takeaways 12. South Asia & Pacific Real-Time E-Healthcare System Market Analysis 2017-2021 and Forecast 2022-2032, By Country 12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 12.2.1. By Country 12.2.1.1. India 12.2.1.2. Thailand 12.2.1.3. Indonesia 12.2.1.4. Malaysia 12.2.1.5. Singapore 12.2.1.6. Australia 12.2.1.7. New Zealand 12.2.1.8. Rest of South Asia & Pacific 12.2.2. By Product Type 12.2.3. By Distribution Channel 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Product Type 12.3.3. By Distribution Channel 12.4. Key Takeaways 13. MEA Real-Time E-Healthcare System Market Analysis 2017-2021 and Forecast 2022-2032, By Country 13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 13.2.1. By Country 13.2.1.1. GCC Countries 13.2.1.2. South Africa 13.2.1.3. Israel 13.2.1.4. Rest of MEA 13.2.2. By Product Type 13.2.3. By Distribution Channel 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Product Type 13.3.3. By Distribution Channel 13.4. Key Takeaways 14. Key Countries Real-Time E-Healthcare System Market Analysis 14.1. U.S. 14.1.1. Pricing Analysis 14.1.2. Market Share Analysis, 2021 14.1.2.1. By Product Type 14.1.2.2. By Distribution Channel 14.2. Canada 14.2.1. Pricing Analysis 14.2.2. Market Share Analysis, 2021 14.2.2.1. By Product Type 14.2.2.2. By Distribution Channel 14.3. Brazil 14.3.1. Pricing Analysis 14.3.2. Market Share Analysis, 2021 14.3.2.1. By Product Type 14.3.2.2. By Distribution Channel 14.4. Mexico 14.4.1. Pricing Analysis 14.4.2. Market Share Analysis, 2021 14.4.2.1. By Product Type 14.4.2.2. By Distribution Channel 14.5. Germany 14.5.1. Pricing Analysis 14.5.2. Market Share Analysis, 2021 14.5.2.1. By Product Type 14.5.2.2. By Distribution Channel 14.6. U.K. 14.6.1. Pricing Analysis 14.6.2. Market Share Analysis, 2021 14.6.2.1. By Product Type 14.6.2.2. By Distribution Channel 14.7. France 14.7.1. Pricing Analysis 14.7.2. Market Share Analysis, 2021 14.7.2.1. By Product Type 14.7.2.2. By Distribution Channel 14.8. Spain 14.8.1. Pricing Analysis 14.8.2. Market Share Analysis, 2021 14.8.2.1. By Product Type 14.8.2.2. By Distribution Channel 14.9. Italy 14.9.1. Pricing Analysis 14.9.2. Market Share Analysis, 2021 14.9.2.1. By Product Type 14.9.2.2. By Distribution Channel 14.10. China 14.10.1. Pricing Analysis 14.10.2. Market Share Analysis, 2021 14.10.2.1. By Product Type 14.10.2.2. By Distribution Channel 14.11. Japan 14.11.1. Pricing Analysis 14.11.2. Market Share Analysis, 2021 14.11.2.1. By Product Type 14.11.2.2. By Distribution Channel 14.12. South Korea 14.12.1. Pricing Analysis 14.12.2. Market Share Analysis, 2021 14.12.2.1. By Product Type 14.12.2.2. By Distribution Channel 14.13. India 14.13.1. Pricing Analysis 14.13.2. Market Share Analysis, 2021 14.13.2.1. By Product Type 14.13.2.2. By Distribution Channel 14.14. Thailand 14.14.1. Pricing Analysis 14.14.2. Market Share Analysis, 2021 14.14.2.1. By Product Type 14.14.2.2. By Distribution Channel 14.15. Indonesia 14.15.1. Pricing Analysis 14.15.2. Market Share Analysis, 2021 14.15.2.1. By Product Type 14.15.2.2. By Distribution Channel 14.16. Malaysia 14.16.1. Pricing Analysis 14.16.2. Market Share Analysis, 2021 14.16.2.1. By Product Type 14.16.2.2. By Distribution Channel 14.17. Singapore 14.17.1. Pricing Analysis 14.17.2. Market Share Analysis, 2021 14.17.2.1. By Product Type 14.17.2.2. By Distribution Channel 14.18. Australia 14.18.1. Pricing Analysis 14.18.2. Market Share Analysis, 2021 14.18.2.1. By Product Type 14.18.2.2. By Distribution Channel 14.19. New Zealand 14.19.1. Pricing Analysis 14.19.2. Market Share Analysis, 2021 14.19.2.1. By Product Type 14.19.2.2. By Distribution Channel 14.20. GCC Countries 14.20.1. Pricing Analysis 14.20.2. Market Share Analysis, 2021 14.20.2.1. By Product Type 14.20.2.2. By Distribution Channel 14.21. South Africa 14.21.1. Pricing Analysis 14.21.2. Market Share Analysis, 2021 14.21.2.1. By Product Type 14.21.2.2. By Distribution Channel 14.22. Israel 14.22.1. Pricing Analysis 14.22.2. Market Share Analysis, 2021 14.22.2.1. By Product Type 14.22.2.2. By Distribution Channel 15. Market Structure Analysis 15.1. Competition Dashboard 15.2. Competition Benchmarking 15.3. Market Share Analysis of Top Players 15.3.1. By Regional 15.3.2. By Product Type 15.3.3. By Distribution Channel 16. Competition Analysis 16.1. Competition Deep Dive 16.1.1. Fitbit, Inc. 16.1.1.1. Overview 16.1.1.2. Product Portfolio 16.1.1.3. Profitability by Market Segments 16.1.1.4. Sales Footprint 16.1.1.5. Strategy Overview 16.1.1.5.1. Marketing Strategy 16.1.1.5.2. Product Strategy 16.1.1.5.3. Channel Strategy 16.1.2. Garmin Ltd 16.1.2.1. Overview 16.1.2.2. Product Portfolio 16.1.2.3. Profitability by Market Segments 16.1.2.4. Sales Footprint 16.1.2.5. Strategy Overview 16.1.2.5.1. Marketing Strategy 16.1.2.5.2. Product Strategy 16.1.2.5.3. Channel Strategy 16.1.3. Jawbone 16.1.3.1. Overview 16.1.3.2. Product Portfolio 16.1.3.3. Profitability by Market Segments 16.1.3.4. Sales Footprint 16.1.3.5. Strategy Overview 16.1.3.5.1. Marketing Strategy 16.1.3.5.2. Product Strategy 16.1.3.5.3. Channel Strategy 16.1.4. Dexcom, Inc. 16.1.4.1. Overview 16.1.4.2. Product Portfolio 16.1.4.3. Profitability by Market Segments 16.1.4.4. Sales Footprint 16.1.4.5. Strategy Overview 16.1.4.5.1. Marketing Strategy 16.1.4.5.2. Product Strategy 16.1.4.5.3. Channel Strategy 16.1.5. Medtronic 16.1.5.1. Overview 16.1.5.2. Product Portfolio 16.1.5.3. Profitability by Market Segments 16.1.5.4. Sales Footprint 16.1.5.5. Strategy Overview 16.1.5.5.1. Marketing Strategy 16.1.5.5.2. Product Strategy 16.1.5.5.3. Channel Strategy 16.1.6. Abbott Laboratories 16.1.6.1. Overview 16.1.6.2. Product Portfolio 16.1.6.3. Profitability by Market Segments 16.1.6.4. Sales Footprint 16.1.6.5. Strategy Overview 16.1.6.5.1. Marketing Strategy 16.1.6.5.2. Product Strategy 16.1.6.5.3. Channel Strategy 16.1.7. Cerner Corporation 16.1.7.1. Overview 16.1.7.2. Product Portfolio 16.1.7.3. Profitability by Market Segments 16.1.7.4. Sales Footprint 16.1.7.5. Strategy Overview 16.1.7.5.1. Marketing Strategy 16.1.7.5.2. Product Strategy 16.1.7.5.3. Channel Strategy 16.1.8. GE Healthcare 16.1.8.1. Overview 16.1.8.2. Product Portfolio 16.1.8.3. Profitability by Market Segments 16.1.8.4. Sales Footprint 16.1.8.5. Strategy Overview 16.1.8.5.1. Marketing Strategy 16.1.8.5.2. Product Strategy 16.1.8.5.3. Channel Strategy 16.1.9. Epic Systems Corporation 16.1.9.1. Overview 16.1.9.2. Product Portfolio 16.1.9.3. Profitability by Market Segments 16.1.9.4. Sales Footprint 16.1.9.5. Strategy Overview 16.1.9.5.1. Marketing Strategy 16.1.9.5.2. Product Strategy 16.1.9.5.3. Channel Strategy 16.1.10. Medtronic plc 16.1.10.1. Overview 16.1.10.2. Product Portfolio 16.1.10.3. Profitability by Market Segments 16.1.10.4. Sales Footprint 16.1.10.5. Strategy Overview 16.1.10.5.1. Marketing Strategy 16.1.10.5.2. Product Strategy 16.1.10.5.3. Channel Strategy 16.1.11. Arcadia Healthcare Solutions 16.1.11.1. Overview 16.1.11.2. Product Portfolio 16.1.11.3. Profitability by Market Segments 16.1.11.4. Sales Footprint 16.1.11.5. Strategy Overview 16.1.11.5.1. Marketing Strategy 16.1.11.5.2. Product Strategy 16.1.11.5.3. Channel Strategy 16.1.12. Omada Health 16.1.12.1. Overview 16.1.12.2. Product Portfolio 16.1.12.3. Profitability by Market Segments 16.1.12.4. Sales Footprint 16.1.12.5. Strategy Overview 16.1.12.5.1. Marketing Strategy 16.1.12.5.2. Product Strategy 16.1.12.5.3. Channel Strategy 16.1.13. Comarch SA 16.1.13.1. Overview 16.1.13.2. Product Portfolio 16.1.13.3. Profitability by Market Segments 16.1.13.4. Sales Footprint 16.1.13.5. Strategy Overview 16.1.13.5.1. Marketing Strategy 16.1.13.5.2. Product Strategy 16.1.13.5.3. Channel Strategy 16.1.14. Renesas Electronics Corporation 16.1.14.1. Overview 16.1.14.2. Product Portfolio 16.1.14.3. Profitability by Market Segments 16.1.14.4. Sales Footprint 16.1.14.5. Strategy Overview 16.1.14.5.1. Marketing Strategy 16.1.14.5.2. Product Strategy 16.1.14.5.3. Channel Strategy 16.1.15. MDs, Inc. 16.1.15.1. Overview 16.1.15.2. Product Portfolio 16.1.15.3. Profitability by Market Segments 16.1.15.4. Sales Footprint 16.1.15.5. Strategy Overview 16.1.15.5.1. Marketing Strategy 16.1.15.5.2. Product Strategy 16.1.15.5.3. Channel Strategy 16.1.16. Archer 16.1.16.1. Overview 16.1.16.2. Product Portfolio 16.1.16.3. Profitability by Market Segments 16.1.16.4. Sales Footprint 16.1.16.5. Strategy Overview 16.1.16.5.1. Marketing Strategy 16.1.16.5.2. Product Strategy 16.1.16.5.3. Channel Strategy 16.1.17. Cloud IT Solutions 16.1.17.1. Overview 16.1.17.2. Product Portfolio 16.1.17.3. Profitability by Market Segments 16.1.17.4. Sales Footprint 16.1.17.5. Strategy Overview 16.1.17.5.1. Marketing Strategy 16.1.17.5.2. Product Strategy 16.1.17.5.3. Channel Strategy 16.1.18. Cisco Systems 16.1.18.1. Overview 16.1.18.2. Product Portfolio 16.1.18.3. Profitability by Market Segments 16.1.18.4. Sales Footprint 16.1.18.5. Strategy Overview 16.1.18.5.1. Marketing Strategy 16.1.18.5.2. Product Strategy 16.1.18.5.3. Channel Strategy 17. Assumptions & Acronyms Used 18. Research Methodology
SummaryA real-time e-healthcare system is one of the best ways to keep your health records and track them anytime, without any geographical constraint. Patients can always stay in touch with their doctors and communicate with them about any health issue. They can self-check also for an immediate result without any third party’s dependence. With advanced technology and rapid innovation, these days’ products are being made in such a way that they should be more consumer-friendly and easy to use. Real-time e-healthcare system fulfills all the above criteria and hence, the market is growing at a positive rate. Table of Contents1. Executive Summary1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Product Life Cycle Analysis 3.5. Supply Chain Analysis 3.5.1. Supply Side Participants and their Roles 3.5.1.1. Producers 3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers) 3.5.1.3. Wholesalers and Distributors 3.5.2. Value Added and Value Created at Node in the Supply Chain 3.5.3. List of Raw Material Suppliers 3.5.4. List of Existing and Potential Buyer’s 3.6. Investment Feasibility Matrix 3.7. Value Chain Analysis 3.7.1. Profit Margin Analysis 3.7.2. Wholesalers and Distributors 3.7.3. Retailers 3.8. PESTLE and Porter’s Analysis 3.9. Regulatory Landscape 3.9.1. By Key Regions 3.9.2. By Key Countries 3.10. Regional Parent Market Outlook 3.11. Production and Consumption Statistics 3.12. Import and Export Statistics 4. Global Real-Time E-Healthcare System Market Analysis 2017-2021 and Forecast, 2022-2032 4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021 4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Real-Time E-Healthcare System Market Analysis 2017-2021 and Forecast 2022-2032, By Product Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Mn) Analysis By Product Type, 2017-2021 5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Product Type, 2022-2032 5.3.1. Wireless Body Sensor Network Based e-healthcare Systems 5.3.2. Cellular and Smartphone Based e-Healthcare Systems 5.3.3. System on Chip e-healthcare System 5.3.4. Cloud-based e-healthcare Systems 5.4. Y-o-Y Growth Trend Analysis By Product Type, 2017-2021 5.5. Absolute $ Opportunity Analysis By Product Type, 2022-2032 Deep-dive segmentation will be available in the sample on request 6. Global Real-Time E-Healthcare System Market Analysis 2017-2021 and Forecast 2022-2032, By Distribution Channel 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Mn) Analysis By Distribution Channel, 2017-2021 6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2022-2032 6.3.1. Institutional Sales 6.3.2. Retail Sales 6.4. Y-o-Y Growth Trend Analysis By Distribution Channel, 2017-2021 6.5. Absolute $ Opportunity Analysis By Distribution Channel, 2022-2032 Deep-dive segmentation will be available in the sample on request 7. Global Real-Time E-Healthcare System Market Analysis 2017-2021 and Forecast 2022-2032, By Region 7.1. Introduction 7.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021 7.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032 7.3.1. North America 7.3.2. Latin America 7.3.3. Europe 7.3.4. East Asia 7.3.5. South Asia & Pacific 7.3.6. MEA 7.4. Market Attractiveness Analysis By Region 8. North America Real-Time E-Healthcare System Market Analysis 2017-2021 and Forecast 2022-2032, By Country 8.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 8.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 8.2.1. By Country 8.2.1.1. U.S. 8.2.1.2. Canada 8.2.2. By Product Type 8.2.3. By Distribution Channel 8.3. Market Attractiveness Analysis 8.3.1. By Country 8.3.2. By Product Type 8.3.3. By Distribution Channel 8.4. Key Takeaways 9. Latin America Real-Time E-Healthcare System Market Analysis 2017-2021 and Forecast 2022-2032, By Country 9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 9.2.1. By Country 9.2.1.1. Brazil 9.2.1.2. Mexico 9.2.1.3. Rest of Latin America 9.2.2. By Product Type 9.2.3. By Distribution Channel 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Product Type 9.3.3. By Distribution Channel 9.4. Key Takeaways 10. Europe Real-Time E-Healthcare System Market Analysis 2017-2021 and Forecast 2022-2032, By Country 10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 10.2.1. By Country 10.2.1.1. Germany 10.2.1.2. U.K. 10.2.1.3. France 10.2.1.4. Spain 10.2.1.5. Italy 10.2.1.6. Rest of Europe 10.2.2. By Product Type 10.2.3. By Distribution Channel 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Product Type 10.3.3. By Distribution Channel 10.4. Key Takeaways 11. East Asia Real-Time E-Healthcare System Market Analysis 2017-2021 and Forecast 2022-2032, By Country 11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 11.2.1. By Country 11.2.1.1. China 11.2.1.2. Japan 11.2.1.3. South Korea 11.2.2. By Product Type 11.2.3. By Distribution Channel 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Product Type 11.3.3. By Distribution Channel 11.4. Key Takeaways 12. South Asia & Pacific Real-Time E-Healthcare System Market Analysis 2017-2021 and Forecast 2022-2032, By Country 12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 12.2.1. By Country 12.2.1.1. India 12.2.1.2. Thailand 12.2.1.3. Indonesia 12.2.1.4. Malaysia 12.2.1.5. Singapore 12.2.1.6. Australia 12.2.1.7. New Zealand 12.2.1.8. Rest of South Asia & Pacific 12.2.2. By Product Type 12.2.3. By Distribution Channel 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Product Type 12.3.3. By Distribution Channel 12.4. Key Takeaways 13. MEA Real-Time E-Healthcare System Market Analysis 2017-2021 and Forecast 2022-2032, By Country 13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 13.2.1. By Country 13.2.1.1. GCC Countries 13.2.1.2. South Africa 13.2.1.3. Israel 13.2.1.4. Rest of MEA 13.2.2. By Product Type 13.2.3. By Distribution Channel 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Product Type 13.3.3. By Distribution Channel 13.4. Key Takeaways 14. Key Countries Real-Time E-Healthcare System Market Analysis 14.1. U.S. 14.1.1. Pricing Analysis 14.1.2. Market Share Analysis, 2021 14.1.2.1. By Product Type 14.1.2.2. By Distribution Channel 14.2. Canada 14.2.1. Pricing Analysis 14.2.2. Market Share Analysis, 2021 14.2.2.1. By Product Type 14.2.2.2. By Distribution Channel 14.3. Brazil 14.3.1. Pricing Analysis 14.3.2. Market Share Analysis, 2021 14.3.2.1. By Product Type 14.3.2.2. By Distribution Channel 14.4. Mexico 14.4.1. Pricing Analysis 14.4.2. Market Share Analysis, 2021 14.4.2.1. By Product Type 14.4.2.2. By Distribution Channel 14.5. Germany 14.5.1. Pricing Analysis 14.5.2. Market Share Analysis, 2021 14.5.2.1. By Product Type 14.5.2.2. By Distribution Channel 14.6. U.K. 14.6.1. Pricing Analysis 14.6.2. Market Share Analysis, 2021 14.6.2.1. By Product Type 14.6.2.2. By Distribution Channel 14.7. France 14.7.1. Pricing Analysis 14.7.2. Market Share Analysis, 2021 14.7.2.1. By Product Type 14.7.2.2. By Distribution Channel 14.8. Spain 14.8.1. Pricing Analysis 14.8.2. Market Share Analysis, 2021 14.8.2.1. By Product Type 14.8.2.2. By Distribution Channel 14.9. Italy 14.9.1. Pricing Analysis 14.9.2. Market Share Analysis, 2021 14.9.2.1. By Product Type 14.9.2.2. By Distribution Channel 14.10. China 14.10.1. Pricing Analysis 14.10.2. Market Share Analysis, 2021 14.10.2.1. By Product Type 14.10.2.2. By Distribution Channel 14.11. Japan 14.11.1. Pricing Analysis 14.11.2. Market Share Analysis, 2021 14.11.2.1. By Product Type 14.11.2.2. By Distribution Channel 14.12. South Korea 14.12.1. Pricing Analysis 14.12.2. Market Share Analysis, 2021 14.12.2.1. By Product Type 14.12.2.2. By Distribution Channel 14.13. India 14.13.1. Pricing Analysis 14.13.2. Market Share Analysis, 2021 14.13.2.1. By Product Type 14.13.2.2. By Distribution Channel 14.14. Thailand 14.14.1. Pricing Analysis 14.14.2. Market Share Analysis, 2021 14.14.2.1. By Product Type 14.14.2.2. By Distribution Channel 14.15. Indonesia 14.15.1. Pricing Analysis 14.15.2. Market Share Analysis, 2021 14.15.2.1. By Product Type 14.15.2.2. By Distribution Channel 14.16. Malaysia 14.16.1. Pricing Analysis 14.16.2. Market Share Analysis, 2021 14.16.2.1. By Product Type 14.16.2.2. By Distribution Channel 14.17. Singapore 14.17.1. Pricing Analysis 14.17.2. Market Share Analysis, 2021 14.17.2.1. By Product Type 14.17.2.2. By Distribution Channel 14.18. Australia 14.18.1. Pricing Analysis 14.18.2. Market Share Analysis, 2021 14.18.2.1. By Product Type 14.18.2.2. By Distribution Channel 14.19. New Zealand 14.19.1. Pricing Analysis 14.19.2. Market Share Analysis, 2021 14.19.2.1. By Product Type 14.19.2.2. By Distribution Channel 14.20. GCC Countries 14.20.1. Pricing Analysis 14.20.2. Market Share Analysis, 2021 14.20.2.1. By Product Type 14.20.2.2. By Distribution Channel 14.21. South Africa 14.21.1. Pricing Analysis 14.21.2. Market Share Analysis, 2021 14.21.2.1. By Product Type 14.21.2.2. By Distribution Channel 14.22. Israel 14.22.1. Pricing Analysis 14.22.2. Market Share Analysis, 2021 14.22.2.1. By Product Type 14.22.2.2. By Distribution Channel 15. Market Structure Analysis 15.1. Competition Dashboard 15.2. Competition Benchmarking 15.3. Market Share Analysis of Top Players 15.3.1. By Regional 15.3.2. By Product Type 15.3.3. By Distribution Channel 16. Competition Analysis 16.1. Competition Deep Dive 16.1.1. Fitbit, Inc. 16.1.1.1. Overview 16.1.1.2. Product Portfolio 16.1.1.3. Profitability by Market Segments 16.1.1.4. Sales Footprint 16.1.1.5. Strategy Overview 16.1.1.5.1. Marketing Strategy 16.1.1.5.2. Product Strategy 16.1.1.5.3. Channel Strategy 16.1.2. Garmin Ltd 16.1.2.1. Overview 16.1.2.2. Product Portfolio 16.1.2.3. Profitability by Market Segments 16.1.2.4. Sales Footprint 16.1.2.5. Strategy Overview 16.1.2.5.1. Marketing Strategy 16.1.2.5.2. Product Strategy 16.1.2.5.3. Channel Strategy 16.1.3. Jawbone 16.1.3.1. Overview 16.1.3.2. Product Portfolio 16.1.3.3. Profitability by Market Segments 16.1.3.4. Sales Footprint 16.1.3.5. Strategy Overview 16.1.3.5.1. Marketing Strategy 16.1.3.5.2. Product Strategy 16.1.3.5.3. Channel Strategy 16.1.4. Dexcom, Inc. 16.1.4.1. Overview 16.1.4.2. Product Portfolio 16.1.4.3. Profitability by Market Segments 16.1.4.4. Sales Footprint 16.1.4.5. Strategy Overview 16.1.4.5.1. Marketing Strategy 16.1.4.5.2. Product Strategy 16.1.4.5.3. Channel Strategy 16.1.5. Medtronic 16.1.5.1. Overview 16.1.5.2. Product Portfolio 16.1.5.3. Profitability by Market Segments 16.1.5.4. Sales Footprint 16.1.5.5. Strategy Overview 16.1.5.5.1. Marketing Strategy 16.1.5.5.2. Product Strategy 16.1.5.5.3. Channel Strategy 16.1.6. Abbott Laboratories 16.1.6.1. Overview 16.1.6.2. Product Portfolio 16.1.6.3. Profitability by Market Segments 16.1.6.4. Sales Footprint 16.1.6.5. Strategy Overview 16.1.6.5.1. Marketing Strategy 16.1.6.5.2. Product Strategy 16.1.6.5.3. Channel Strategy 16.1.7. Cerner Corporation 16.1.7.1. Overview 16.1.7.2. Product Portfolio 16.1.7.3. Profitability by Market Segments 16.1.7.4. Sales Footprint 16.1.7.5. Strategy Overview 16.1.7.5.1. Marketing Strategy 16.1.7.5.2. Product Strategy 16.1.7.5.3. Channel Strategy 16.1.8. GE Healthcare 16.1.8.1. Overview 16.1.8.2. Product Portfolio 16.1.8.3. Profitability by Market Segments 16.1.8.4. Sales Footprint 16.1.8.5. Strategy Overview 16.1.8.5.1. Marketing Strategy 16.1.8.5.2. Product Strategy 16.1.8.5.3. Channel Strategy 16.1.9. Epic Systems Corporation 16.1.9.1. Overview 16.1.9.2. Product Portfolio 16.1.9.3. Profitability by Market Segments 16.1.9.4. Sales Footprint 16.1.9.5. Strategy Overview 16.1.9.5.1. Marketing Strategy 16.1.9.5.2. Product Strategy 16.1.9.5.3. Channel Strategy 16.1.10. Medtronic plc 16.1.10.1. Overview 16.1.10.2. Product Portfolio 16.1.10.3. Profitability by Market Segments 16.1.10.4. Sales Footprint 16.1.10.5. Strategy Overview 16.1.10.5.1. Marketing Strategy 16.1.10.5.2. Product Strategy 16.1.10.5.3. Channel Strategy 16.1.11. Arcadia Healthcare Solutions 16.1.11.1. Overview 16.1.11.2. Product Portfolio 16.1.11.3. Profitability by Market Segments 16.1.11.4. Sales Footprint 16.1.11.5. Strategy Overview 16.1.11.5.1. Marketing Strategy 16.1.11.5.2. Product Strategy 16.1.11.5.3. Channel Strategy 16.1.12. Omada Health 16.1.12.1. Overview 16.1.12.2. Product Portfolio 16.1.12.3. Profitability by Market Segments 16.1.12.4. Sales Footprint 16.1.12.5. Strategy Overview 16.1.12.5.1. Marketing Strategy 16.1.12.5.2. Product Strategy 16.1.12.5.3. Channel Strategy 16.1.13. Comarch SA 16.1.13.1. Overview 16.1.13.2. Product Portfolio 16.1.13.3. Profitability by Market Segments 16.1.13.4. Sales Footprint 16.1.13.5. Strategy Overview 16.1.13.5.1. Marketing Strategy 16.1.13.5.2. Product Strategy 16.1.13.5.3. Channel Strategy 16.1.14. Renesas Electronics Corporation 16.1.14.1. Overview 16.1.14.2. Product Portfolio 16.1.14.3. Profitability by Market Segments 16.1.14.4. Sales Footprint 16.1.14.5. Strategy Overview 16.1.14.5.1. Marketing Strategy 16.1.14.5.2. Product Strategy 16.1.14.5.3. Channel Strategy 16.1.15. MDs, Inc. 16.1.15.1. Overview 16.1.15.2. Product Portfolio 16.1.15.3. Profitability by Market Segments 16.1.15.4. Sales Footprint 16.1.15.5. Strategy Overview 16.1.15.5.1. Marketing Strategy 16.1.15.5.2. Product Strategy 16.1.15.5.3. Channel Strategy 16.1.16. Archer 16.1.16.1. Overview 16.1.16.2. Product Portfolio 16.1.16.3. Profitability by Market Segments 16.1.16.4. Sales Footprint 16.1.16.5. Strategy Overview 16.1.16.5.1. Marketing Strategy 16.1.16.5.2. Product Strategy 16.1.16.5.3. Channel Strategy 16.1.17. Cloud IT Solutions 16.1.17.1. Overview 16.1.17.2. Product Portfolio 16.1.17.3. Profitability by Market Segments 16.1.17.4. Sales Footprint 16.1.17.5. Strategy Overview 16.1.17.5.1. Marketing Strategy 16.1.17.5.2. Product Strategy 16.1.17.5.3. Channel Strategy 16.1.18. Cisco Systems 16.1.18.1. Overview 16.1.18.2. Product Portfolio 16.1.18.3. Profitability by Market Segments 16.1.18.4. Sales Footprint 16.1.18.5. Strategy Overview 16.1.18.5.1. Marketing Strategy 16.1.18.5.2. Product Strategy 16.1.18.5.3. Channel Strategy 17. Assumptions & Acronyms Used 18. Research Methodology
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療)の最新刊レポート
Future Market Insights社の医療・製薬・メディカルデバイス分野での最新刊レポート本レポートと同じKEY WORD()の最新刊レポート
よくあるご質問Future Market Insights社はどのような調査会社ですか?Future Market Insights(FMI)は世界の広範な地域および産業を対象にした調査レポートを出版しています。 弊社ウェブサイトに掲載のないタイトルも全てお取り扱い可能ですので... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/12/18 10:27 154.74 円 162.88 円 199.42 円 |